Literature DB >> 19871191

STUDIES ON THE ANTIBACTERIAL ACTION OF THE SULFONAMIDE DRUGS : II. THE POSSIBLE RELATION OF DRUG ACTIVITY TO SUBSTANCES OTHER THANp-AMINOBENZOIC ACID.

W B Wood1, R Austrian.   

Abstract

1. In cultures of Staphylococus aureus in a synthetic medium nicotinamide and cozymase were shown to block the bacteriostatic action of chemically unrelated sulfonamide drugs as well as the chemically related compound sulfapyridine. The antibacterial properties of organic dyes totally unrelated to the sulfonamide compounds (methylene blue and thionine) were also nullified by the addition of cozymase to the culture medium. 2. The antagonistic action of the pyridine-containing coenzyme, cozymase, was found, by quantitative study, to be no greater against sulfapyridine than against other structurally dissimilar sulfonamide compounds. 3. The antidrug effects of nicotinamide and cozymase in staphylococcus cultures were observed to be directly proportional to their ability to stimulate the growth of the organism in the synthetic medium. When tested in cultures of B. coli in which they failed to accelerate bacterial growth, these same substances failed to influence the bacteriostatic action of the sulfonamide drugs. 4. The in vitro action of the coenzyme, cocarboxylase, as measured in the Warburg respirometer, was shown to be unaffected by the chemically related drug, sulfathiazole, even when the latter was present in great excess. The above observations fail to support the theory that sulfapyridine, sulfathiazole, and sulfadiazine prevent bacterial growth by interfering with the functioning of the chemically related coenzymes, cozymase, and cocarboxylase. The mode of action of sulfanilamide and its more common derivatives is discussed in the light of these observations, and a tentative theory is offered to explain the differences in bacteriostatic potency exhibited by the various sulfonamide compounds.

Entities:  

Year:  1942        PMID: 19871191      PMCID: PMC2135253          DOI: 10.1084/jem.75.4.383

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  4 in total

1.  Some properties of the dehydrogenating enzymes of bacteria.

Authors:  J H Quastel; W R Wooldridge
Journal:  Biochem J       Date:  1928       Impact factor: 3.857

2.  Dehydrogenations produced by resting Bacteria. I.

Authors:  J H Quastel; M D Whetham
Journal:  Biochem J       Date:  1925       Impact factor: 3.857

3.  STUDIES ON THE ANTIBACTERIAL ACTION OF THE SULFONAMIDE DRUGS : I. THE RELATION OFp-AMINOBENZOIC ACID TO THE MECHANISM OF BACTERIOSTASIS.

Authors:  W B Wood
Journal:  J Exp Med       Date:  1942-04-01       Impact factor: 14.307

4.  THE RELATION OF THE BACTERIOSTATIC ACTION OF CERTAIN DYES TO OXIDATION-REDUCTION PROCESSES.

Authors:  R Dubos
Journal:  J Exp Med       Date:  1929-03-31       Impact factor: 14.307

  4 in total
  4 in total

Review 1.  Sulfonamide drugs: structure, antibacterial property, toxicity, and biophysical interactions.

Authors:  Aben Ovung; Jhimli Bhattacharyya
Journal:  Biophys Rev       Date:  2021-03-29

2.  THE OXIDATION OF p-AMINOBENZOIC ACID AND ANTHRANILIC ACID BY SPECIFICALLY ADAPTED ENZYMES OF A SOIL BACILLUS.

Authors:  G S Mirick
Journal:  J Exp Med       Date:  1943-10-01       Impact factor: 14.307

3.  STUDIES ON THE ANTIBACTERIAL ACTION OF THE SULFONAMIDE DRUGS : I. THE RELATION OFp-AMINOBENZOIC ACID TO THE MECHANISM OF BACTERIOSTASIS.

Authors:  W B Wood
Journal:  J Exp Med       Date:  1942-04-01       Impact factor: 14.307

4.  Antioxidative Activity of 1,3,5-Triazine Analogues Incorporating Aminobenzene Sulfonamide, Aminoalcohol/Phenol, Piperazine, Chalcone, or Stilbene Motifs.

Authors:  Eva Havránková; Nikola Čalkovská; Tereza Padrtová; Jozef Csöllei; Radka Opatřilová; Pavel Pazdera
Journal:  Molecules       Date:  2020-04-14       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.